Dual-action drug produces shows promising results in neuroendocrine tumor trial

A drug that simultaneously strikes cancer cells’ growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.

Are We Testing Enough for H5N1?

With H5N1 avian influenza causing unprecedented outbreaks in mammals around the world — including U.S. dairy cattle — infectious disease experts are raising concerns that

April 26, 2024

Study uncovers unexpected level of complexity hidden within neutrophils

In a study published in Cell on March 5, Prof. Zhang Xiaoming at the Shanghai Institute of Immunity and Infection (SIII) of the Chinese Academy

March 7, 2024

New tool predicts health risks from heat and cold waves

Ambient temperatures are associated with over 5 million premature deaths worldwide every year, more than 300,000 of which in Western Europe alone.

June 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.